Partial imaging and laboratory data of the patients
| . | Severe sequelae group (n = 28) . | Mild sequelae group (n = 46) . | P value . |
|---|---|---|---|
| Hemorrhage | | | |
| Data available | 28 | 46 | |
| Number of patients | 11/28 (39.2%) | 5/46 (10.8%) | 0.007 |
| Time duration from onset to neurological symptoms | | | |
| Data available | 6 | 19 | |
| Time duration (median; day) | 8.5 | 4 | 0.386 |
| CSF test | | | |
| Data available | 9 | 31 | |
| CSF protein level (median; mg/dl) | 230 | 78 | 0.200 |
| Blood test | | | |
| CRP | | | |
| Data available | 18 | 22 | |
| CRP level (median; mg/L) | 39.6 | 11.6 | 0.005 |
| D-dimer | | | |
| Data available | 14 | 17 | |
| D-dimer level (median; μg/ml) | 8.7 | 3.7 | 0.076 |
| . | Severe sequelae group (n = 28) . | Mild sequelae group (n = 46) . | P value . |
|---|---|---|---|
| Hemorrhage | | | |
| Data available | 28 | 46 | |
| Number of patients | 11/28 (39.2%) | 5/46 (10.8%) | 0.007 |
| Time duration from onset to neurological symptoms | | | |
| Data available | 6 | 19 | |
| Time duration (median; day) | 8.5 | 4 | 0.386 |
| CSF test | | | |
| Data available | 9 | 31 | |
| CSF protein level (median; mg/dl) | 230 | 78 | 0.200 |
| Blood test | | | |
| CRP | | | |
| Data available | 18 | 22 | |
| CRP level (median; mg/L) | 39.6 | 11.6 | 0.005 |
| D-dimer | | | |
| Data available | 14 | 17 | |
| D-dimer level (median; μg/ml) | 8.7 | 3.7 | 0.076 |